Evidence map›Paper›PMID 40811856›Full record

ArticleBlood2025

Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism.

Josepha C Sedzro, Amanda L Photenhauer, Fabienne Birkle, Katarina Meze, Alex Mortenson, Cade Duckworth, Po-Chao Wen, Sarah Kearns, Michael A Cianfrocco, Emad Tajkhorshid and 2 more

Abstract read
In one paragraph

Article in Blood, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Josepha C SedzroDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0001-6577-3029
Amanda L PhotenhauerLife Sciences Institute, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-1553-4772
Fabienne BirkleDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0003-0238-8865
Katarina MezeLife Sciences Institute, University of Michigan, Ann Arbor, MI.ORCID 0000-0003-0849-9304
Alex MortensonTheoretical and Computational Biophysics Group, National Institutes of Health Resource for Macromolecular Modeling and Visualization, Beckman Institute for Advanced Science and Technology, Department of Biochemistry, Center for Biophysics and Quantitative Biology, University of Illinois Urbana-Champaign, Urbana, IL.ORCID 0009-0007-5862-7729
Cade DuckworthTheoretical and Computational Biophysics Group, National Institutes of Health Resource for Macromolecular Modeling and Visualization, Beckman Institute for Advanced Science and Technology, Department of Biochemistry, Center for Biophysics and Quantitative Biology, University of Illinois Urbana-Champaign, Urbana, IL.ORCID 0009-0001-1627-8459
Po-Chao WenTheoretical and Computational Biophysics Group, National Institutes of Health Resource for Macromolecular Modeling and Visualization, Beckman Institute for Advanced Science and Technology, Department of Biochemistry, Center for Biophysics and Quantitative Biology, University of Illinois Urbana-Champaign, Urbana, IL.ORCID 0000-0002-6049-6904
Sarah KearnsLife Sciences Institute, University of Michigan, Ann Arbor, MI.ORCID 0000-0001-5640-909X
Michael A CianfroccoDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-2067-4999
Emad TajkhorshidTheoretical and Computational Biophysics Group, National Institutes of Health Resource for Macromolecular Modeling and Visualization, Beckman Institute for Advanced Science and Technology, Department of Biochemistry, Center for Biophysics and Quantitative Biology, University of Illinois Urbana-Champaign, Urbana, IL.ORCID 0000-0001-8434-1010
Melanie D OhiLife Sciences Institute, University of Michigan, Ann Arbor, MI.ORCID 0000-0003-1750-4793
James H MorrisseyDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-1570-1569

Funding

Resource for Macromolecular Modeling and VisualizationR24GM145965 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Emad Tajkhorshid · 2022 to 2026
$6.2M
Mechanisms in Blood ClottingR35HL135823 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORRISSEY, JAMES H. · 2017 to 2023
$4.8M
Mechanisms in Blood ClottingR35HL171334 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI James H. Morrissey · 2024 to 2026
$2.9M
Compute Cluster for in vitro and in situ Analysis of Molecular MachinesS10OD030275 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OHI, MELANIE DIANE · 2021 to 2021
$600k
NHLBI NIH HHS R35 HL135823NHLBI NIH HHS R35 HL171334NIGMS NIH HHS R24 GM145965NIH HHS S10 OD030275
6 · The paper itself

Abstract

abstractBlood clotting is triggered in hemostasis and thrombosis when the membrane-bound tissue factor (TF)/factor VIIa (FVIIa) complex activates factor X (FX). There are no structures of TF/FVIIa on membranes, with or without FX. Using cryoelectron microscopy (cryo-EM) to address this gap, we assembled TF/FVIIa complexes on nanoscale membrane bilayers (nanodiscs), bound to XK1 and an antibody fragment. XK1 is a FX mimetic whose protease domain is replaced by the first Kunitz-type (K1) domain of the TF pathway inhibitor, whereas 10H10 is a noninhibitory, anti-TF antibody. We determined a cryo-EM structure of a TF/FVIIa/XK1/10H10/nanodisc complex with a resolution of 3.7 Å, allowing us to model all the protein backbones. TF/FVIIa extends perpendicularly from the membrane, interacting with a "handle-shaped" XK1 at 2 locations: the K1 domain docks into FVIIa's active site, whereas the γ-carboxyglutamate-rich (GLA) domain binds to the TF substrate-binding exosite. The FX and FVIIa GLA domains also contact each other and the membrane surface. Except for a minor contact between the first epidermal growth factor (EGF)-like domain of XK1 and TF, the rest of the FX light chain does not interact with TF/FVIIa. The structure reveals a previously unrecognized, membrane-dependent allosteric activation mechanism between FVIIa and TF, in which a serine-rich loop in TF that partially obscures the TF exosite must undergo a shift to allow access of the FX GLA domain to its final binding location on the membrane-bound TF/FVIIa complex. This mechanism also provides a novel explanation for the otherwise puzzling phenomenon of TF encryption/decryption on cell surfaces.

Indexed as

Factor VIIaFactor XThromboplastinAllosteric RegulationCryoelectron MicroscopyHumansModels, MolecularProtein BindingFactor VIIaFactor XThromboplastin

Identifiers

PMID40811856
PMCPMC12397995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.